Skip to content
‹ Back to IndustriesHealthcare

Open Enrollment Season: What Employers and Employees Need to Know Before it Ends

Employers and employees are in the thick of open enrollment season, and the end date is coming to close. For the ACA marketplace, for example, open enrollment ends on January 15, 2023. Overall, companies are going to have to make important decisions about what health insurance they offer to employees, and employees will need to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Employers and employees are in the thick of open enrollment season, and the end date is coming to close. For the ACA marketplace, for example, open enrollment ends on January 15, 2023. Overall, companies are going to have to make important decisions about what health insurance they offer to employees, and employees will need to wade through the options to figure out which plans best suit their needs, whether those are ACA-offered, employer-offered, or otherwise.

Nick Love, a Benefit Strategist at Brinson Benefits breaks down what beneficiaries need to know about this year’s open enrollment seasons, along with some other tips, misconceptions and more for employers and employees alike.

Nick’s Thoughts:

“We typically see employers just not take open enrollment seriously. Unfortunately, that has a pretty big impact for employees in their households. So, I would encourage employers to take open enrollment, seriously, and for employees as well. Take your time evaluating all the options that you have at your disposal.

Compare what your spouse or significant other has through their employer and make the best decision for you and your family based on the things being offered to both you and your spouse. One thing to keep in mind is whatever you decide at open enrollment remains in effect for a full year unless you have a qualifying life event, which, usually includes things like getting married, getting divorced, having a child, those sort of things.

And so, when that happens, you have a very specific timeframe to notify HR. And so that, that timeframe is 30 days. Make sure you do that within that range so that you can make those mid-year. I would say education’s a big deal. Understanding what deductibles are, what co-insurance means what it’s gonna cost when you go to the doctor, those sort of things.

Some of the things that I think we’re gonna see more of in 2023 are folks gravitating towards HSA plans and more, taking on more of a responsibility in terms of what it’s gonna cost them when they go to the doctor and how they’re going to use that information to make the best decision as to where to go, when to go.

I think we’re gonna continue to see telemedicine have a big impact on people’s decisions and really leaning on the ability to speak to a provider via a telephone or through your computer and not having to physically go to a doctor’s office.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Pharma rates its follow-through on diagnostic data 5.2 out of 10 in Diaceutics survey

Pharma rates its follow-through on diagnostic data 5.2 out of 10 in Diaceutics survey

In a Diaceutics survey of 125 US pharma leaders, respondents rated the significance of converting diagnosis into treatment to future commercial success at an average of 7.5 out of 10. They rated their organizations' effectiveness at turning diagnostic insights into coordinated action at just 5.2 out of 10. Separate Diaceutics lung cancer research found the largest gap now occurs at the point of treatment decision.

  • 01Pharma leaders rated their confidence in identifying eligible patients at 6.6 out of 10, their visibility across the patient journey at 5.4 and their effectiveness at turning diagnostic insights into coordinated action at 5.2. The low last score could point to the treatment decision, where Diaceutics' lung cancer research found the largest gap now occurs.
  • 02In US advanced non-small cell lung cancer, Diaceutics found overall patient loss virtually unchanged at 65.1% in 2023 versus 64.4% in 2019, while patient loss at the point of treatment decision rose from 29.2% to 43.3%. For operators, a flat headline rate could hide one step getting worse.
  • 03Senior leaders from several top 20 pharma companies argue diagnostic planning belongs early in development and commercialization, rather than as a testing and adoption fix after launch.

Nov 22, 2026

Frequent use of clinical AI tools rose to 34% in Elsevier's 2026 clinician survey

Elsevier's Clinician of the Future 2026 survey found 49% of clinicians use AI at work. Purpose-built clinical AI is gaining fast. Its frequent use rose from 22% in 2025 to 34% this year, yet 41% of nurses say their views are rarely or never sufficiently considered in important organizational decisions.

  • 01A sharper vendor question: which evidence base grounds the tool's answers, and can a clinician see that source at the moment of use? Transparency and authoritative data top clinicians' own list of what builds trust.

Nov 22, 2026

Zoom's stake in Medaica aims to bring the physical exam into video visits

Zoom Ventures made an undisclosed strategic investment in Medaica, whose FDA-cleared M1 telehealth stethoscope supports real-time remote heart and lung auscultation. Zoom already integrates with EHRs including Epic, Oracle Cerner Millennium and Athenahealth, but an investment is not an integration and no combined product has been announced. Cardiology follow-ups and care facilities are highlighted as likely early use cases.

  • 01Video gave telehealth the patient's face; an FDA-cleared remote stethoscope adds the heartbeat, and Zoom now has a financial stake in that second layer.
  • 02Today's cleared capability is real-time heart and lung auscultation; the wider mix of third-party devices, AI analysis and decision support is still in development.
  • 03For health systems with elderly or rural cardiology panels, the sharper vendor question is how exam findings reach the EHR record of the visit.

Nov 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512